Lacosamide Tablet, Film Coated
Product Images NDC 33342-302

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 33342-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

125 (Lacosamide 100mg 60s)

This is a medication package for Lacosamide tablets containing 100 mg of the active ingredient. The recommended storage temperature is between 20°C to 25°C. The tablets are manufactured for Macleods Pharma USA, Inc. and each pack contains 60 tablets. Additionally, the package includes details for dispensing and dosage instructions.*

FDA Label Image

313 (Lacosamide 150mg 60s)

Each film-coated tablet contains lacosamide, USP 150 mg. The usual dosage information can be found on the package insert provided. This medication should be stored at a temperature between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It is important to keep this medication out of the reach of children and dispense it in a tight container with a child-resistant closure. Manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. This product is made by Oxalis Labs in Princeton, NJ, and Baddi, Himachal Pradesh, INDIA. It comes in a pack of 60 tablets.*

FDA Label Image

000 (Lacosamide 200mg 60s)

This text is a label for Lacosamide tablets, USP, with a strength of 200mg. It includes information about the usual dosage, storage conditions, manufacturer details, and a reminder to dispense the Medication Guide to each patient. The tablets are distributed by Macleods Pharma USA, Inc. and manufactured in India.*

FDA Label Image

369 (Lacosamide 50mg 60s)

This text provides information about a medication in the form of film-coated tablets containing lacosamide, USP 50 mg. The usual dosage should be confirmed by referring to the package insert. The storage temperature recommended is between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It advises to keep the tablets out of reach of children and for pharmacists to dispense them with a child-resistant closure. The manufacturer information includes Macleods Pharmaceuticals Ltd., with a reference to Macleods Pharma USA Inc. and Oxalis Labs, located in Princeton, NJ, and Baddi, Himachal Pradesh, INDIA.*

FDA Label Image

112 (Lacosamide Fig1)

FDA Label Image

113 (Lacosamide Fig2)

FDA Label Image

Fig-3 (Lacosamide Fig3)

This text provides statistical data on the proportion of patients in a study comparing the effectiveness of a placebo versus lacosamide medication. The results show a significant difference between the two groups, with a p-value of 0.001 indicating a notable effect. The hazard ratio (HR) is reported as 0.548, which translates to a risk reduction of 45.2%. Additionally, a 95% confidence interval is provided as [0.381, 0.788]. The number at risk over time is also displayed for both treatment groups.*

FDA Label Image

111 (Lacosamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.